BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29889802)

  • 1. MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance.
    Ecevit ÇÖ; Aktaş S; Tosun Yildirim H; Demirağ B; Erbay A; Karaca İ; Çelik A; Demir AB; Erçetin AP; Olgun N
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):7-12. PubMed ID: 29889802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression might predict prognosis of epithelial hepatoblastoma.
    Gyugos M; Lendvai G; Kenessey I; Schlachter K; Halász J; Nagy P; Garami M; Jakab Z; Schaff Z; Kiss A
    Virchows Arch; 2014 Apr; 464(4):419-27. PubMed ID: 24570391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
    Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
    BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.
    Liu W; Chen S; Liu B
    Pediatr Surg Int; 2016 Nov; 32(11):1059-1065. PubMed ID: 27601233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study.
    Jiao C; Zhu A; Jiao X; Ge J; Xu X
    J Pediatr Surg; 2016 Aug; 51(8):1355-61. PubMed ID: 27046304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.
    von Frowein J; Pagel P; Kappler R; von Schweinitz D; Roscher A; Schmid I
    Hepatology; 2011 Mar; 53(3):833-42. PubMed ID: 21319197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
    Jiao C; Jiao X; Zhu A; Ge J; Xu X
    J Pediatr Surg; 2017 Apr; 52(4):618-624. PubMed ID: 28277300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma.
    Weiss JBW; Wagner AE; Eberherr C; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    Cancer Biomark; 2020; 28(3):321-328. PubMed ID: 32390604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer.
    Wu C; Cao Y; He Z; He J; Hu C; Duan H; Jiang J
    Tohoku J Exp Med; 2014 Feb; 232(2):85-95. PubMed ID: 24531034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High tricellulin expression is associated with better survival in human hepatoblastoma.
    Schlachter K; Gyugos M; Halász J; Lendvai G; Baghy K; Garami M; Gyöngyösi B; Schaff Z; Kiss A
    Histopathology; 2014 Nov; 65(5):631-41. PubMed ID: 24735023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
    Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
    J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-492 regulates metastatic properties of hepatoblastoma via CD44.
    von Frowein J; Hauck SM; Kappler R; Pagel P; Fleischmann KK; Magg T; Cairo S; Roscher A; von Schweinitz D; Schmid I
    Liver Int; 2018 Jul; 38(7):1280-1291. PubMed ID: 29314711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.
    Xiang L; Li M; Liu Y; Cen J; Chen Z; Zhen X; Xie X; Cao X; Gu W
    Ann Hematol; 2013 Aug; 92(8):1063-9. PubMed ID: 23515710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.
    Al-Khanbashi M; Caramuta S; Alajmi AM; Al-Haddabi I; Al-Riyami M; Lui WO; Al-Moundhri MS
    PLoS One; 2016; 11(4):e0152032. PubMed ID: 27064979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
    Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
    Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.
    Lerner C; Wemmert S; Bochen F; Kulas P; Linxweiler M; Hasenfus A; Heinzelmann J; Leidinger P; Backes C; Meese E; Urbschat S; Schick B
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):757-66. PubMed ID: 26621153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
    Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
    Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.